本頁面由Tiger Trade Technology Pte. Ltd.提供服務

神經分泌生物科學

141.84
+0.14000.10%
盤後141.840.00000.00%17:40 EST
成交量:152.09萬
成交額:2.16億
市值:141.42億
市盈率:33.84
高:144.23
開:141.78
低:141.23
收:141.70
52周最高:160.18
52周最低:84.23
股本:9,970.57萬
流通股本:9,800.26萬
量比:1.38
換手率:1.55%
股息:- -
股息率:- -
每股收益(TTM):4.19
每股收益(LYR):3.40
淨資產收益率:14.96%
總資產收益率:8.66%
市淨率:4.71
市盈率(LYR):41.72

資料載入中...

2025/12/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/24

重要事件披露

Form 8-K - Current report
2025/11/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/10/28

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/10/28

重要事件披露

Form 8-K - Current report
2025/08/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/07/30

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/07/30

重要事件披露

Form 8-K - Current report
2025/07/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/07/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/05/30

重要事件披露

Form 8-K - Current report
2025/05/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/05/22

重要事件披露

Form 8-K - Current report
2025/05/21

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/05/21

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments